The groundbreaking therapy of this peptide represents a significant advance in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment